Pearlify UI

Pearlify Data Viewer

read-only

홈 · 표

재무제표 주요계정

보고서별 핵심 계정(매출·이익·자산 등). 계정명은 공시 원문 그대로, 지표는 규칙으로 매핑합니다.

기술 정보 보기 (+11)
수집원발생값 ↑관측 가능 시각법인회사명사업연도기간연결구분재무제표계정명표준 지표금액기준일
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYCFSBS자본총계total_equity7.4조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYCFSIS매출액revenue4.5조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYCFSIS영업이익operating_income2조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYCFSIS법인세차감전 순이익pretax_income2.1조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYCFSIS당기순이익(손실)net_income1.7조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYCFSIS총포괄손익comprehensive_income1.7조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS유동자산current_assets4.3조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS비유동자산non_current_assets6.6조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS자산총계total_assets11조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS유동부채current_liabilities2.5조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS비유동부채non_current_liabilities1조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS부채총계total_liabilities3.6조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS자본금capital_stock1157.2억원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS이익잉여금retained_earnings5조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSBS자본총계total_equity7.4조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSIS매출액revenue4.5조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSIS영업이익operating_income2조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSIS법인세차감전 순이익pretax_income2조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSIS당기순이익(손실)net_income1.5조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,025FYOFSIS총포괄손익comprehensive_income1.5조원2025-12-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS유동자산current_assets4.6조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS비유동자산non_current_assets7.3조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS자산총계total_assets11.9조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS유동부채current_liabilities2.7조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS비유동부채non_current_liabilities1.3조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS부채총계total_liabilities4조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS자본금capital_stock1157.2억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS이익잉여금retained_earnings7.3조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSBS자본총계total_equity7.9조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSIS매출액revenue1.2조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSIS영업이익operating_income5807.5억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSIS법인세차감전 순이익pretax_income6405.9억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSIS당기순이익(손실)net_income4692.4억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1CFSIS총포괄손익comprehensive_income4717.2억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS유동자산current_assets4.5조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS비유동자산non_current_assets7.1조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS자산총계total_assets11.6조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS유동부채current_liabilities2.6조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS비유동부채non_current_liabilities1조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS부채총계total_liabilities3.7조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS자본금capital_stock1157.2억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS이익잉여금retained_earnings5.5조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSBS자본총계total_equity7.8조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSIS매출액revenue1.2조원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSIS영업이익operating_income5805.7억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSIS법인세차감전 순이익pretax_income6454.3억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSIS당기순이익(손실)net_income4741.4억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:06—삼성바이오로직스2,026Q1OFSIS총포괄손익comprehensive_income4732.5억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:02—셀트리온2,026Q1OFSIS총포괄손익comprehensive_income3660.7억원2026-03-31
dart-financials2026-05-152026-07-23 20:12:02—셀트리온2,026Q1OFSIS당기순이익(손실)net_income3650억원2026-03-31
4,008건 중 2,651–2,700← 이전54 / 81 쪽다음 →

fundamental_facts · 컬럼 24개 · occurredAt asc 정렬